Recombinant multi-species IL-13/IL13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-13/IL13 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an immunoregulatory cytokine produced primarily by activated Th2 cells. This cytokine is involved in several stages of B-cell maturation and differentiation. It up-regulates CD23 and MHC class II expression, and promotes IgE isotype switching of B cells. This cytokine down-regulates macrophage activity, thereby inhibits the production of pro-inflammatory cytokines and chemokines. This cytokine is found to be critical to the pathogenesis of allergen-induced asthma but operates through mechanisms independent of IgE and eosinophils. This gene, IL3, IL5, IL4, and CSF2 form a cytokine gene cluster on chromosome 5q, with this gene particularly close to IL4. [provided by RefSeq, Jul 2008]
The Alternative Names of target: IL-13,IL13,Il-13,Il13,Interleukin-13,P600

Target products collectionGo to IL-13/IL13 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T29143-Ag-1/ GM-Tg-hg-T29143-Ag-2 Human IL-13/IL13 protein Human
GM-Tg-rg-T29143-Ag-1/ GM-Tg-rg-T29143-Ag-2 Rat IL-13/IL13 protein Rat
GM-Tg-mg-T29143-Ag-1/ GM-Tg-mg-T29143-Ag-2 Mouse IL-13/IL13 protein Mouse
GM-Tg-cynog-T29143-Ag-1/ GM-Tg-cynog-T29143-Ag-2 Cynomolgus/Rhesus macaque IL-13/IL13 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T29143-Ag-1/ GM-Tg-felg-T29143-Ag-2 Feline IL-13/IL13 protein Feline
GM-Tg-cang-T29143-Ag-1/ GM-Tg-cang-T29143-Ag-2 Canine IL-13/IL13 protein Canine
GM-Tg-bovg-T29143-Ag-1/ GM-Tg-bovg-T29143-Ag-2 Bovine IL-13/IL13 protein Bovine
GM-Tg-equg-T29143-Ag-1/ GM-Tg-equg-T29143-Ag-2 Equine IL-13/IL13 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T29143-Ag-1/ GM-Tg-hg-T29143-Ag-2; GM-Tg-rg-T29143-Ag-1/ GM-Tg-rg-T29143-Ag-2;
GM-Tg-mg-T29143-Ag-1/ GM-Tg-mg-T29143-Ag-2; GM-Tg-cynog-T29143-Ag-1/ GM-Tg-cynog-T29143-Ag-2;
GM-Tg-felg-T29143-Ag-1/ GM-Tg-felg-T29143-Ag-2; GM-Tg-cang-T29143-Ag-1/ GM-Tg-cang-T29143-Ag-2;
GM-Tg-bovg-T29143-Ag-1/ GM-Tg-bovg-T29143-Ag-2; GM-Tg-equg-T29143-Ag-1/ GM-Tg-equg-T29143-Ag-2
Products Name IL-13/IL13 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IL-13/IL13
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-13/IL13 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.